Here’s what you should know:
1. Boston Scientific had $2.41 billion in sales for the fourth quarter of 2017, which is an increase from 2016’s $2.19 billion in sales.
2. Boston Scientific increased full year sales from $8.39 billion in 2016 to $9.05 billion in 2017.
3. The company’s cardiovascular segment was its sales leader, accounting for $3.5 billion in total sales for 2017.
4. Boston Scientific will discuss its fourth quarter and full year sales Feb. 1.
More articles on supply chain:
FDA grants IlluminOss marketing clearance for bone stabilization system
Allscripts to acquire Practice Fusion for $100M: 5 things to know
McKesson completes $735M acquisition of CrossroadsRx: 4 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
